About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
UChicago Medicine 7th Annual Updates from ASH 2021
Videos
Event
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
A
Post-ASH New Strategies in Myeloid Malignancies: AML Treatment
By
UChicago Medicine 7th Annual Updates from ASH 2021
FEATURING
Adam Duvall
By
UChicago Medicine 7th Annual Updates from ASH 2021
FEATURING
Adam Duvall
13 views
March 11, 2022
0 Comments
Login to view comments.
Click here to Login
Featured Video
13:04
Winship Cancer Institute - Emory University
Treatment-Related Quality of Life in MF
Feat.
A. Hunter
Featured Video
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
Videos
11:42
UChicago Medicine 7th Annual Updates from ASH 2021
Post-ASH Case-Based Review of Multiple Myeloma Clinical Trial Consid…
Feat.
J. Cooperrider
13:12
UChicago Medicine 7th Annual Updates from ASH 2021
Post-ASH Case-Based Clinical Trial Considerations: Follicular Lympho…
Feat.
K. Cahill
12:39
UChicago Medicine 7th Annual Updates from ASH 2021
Post-ASH Review Case-Based Clinical Trial Considerations: ALL/AML
Feat.
C. Saygin
13:01
UChicago Medicine 7th Annual Updates from ASH 2021
Post-ASH Case-Based Clinical Trial Considerations: Cellular Therapy …
Feat.
G. Roloff
26:55
UChicago Medicine 7th Annual Updates from ASH 2021
Post-ASH Evolving Standards of Care in Lymphoma
Feat.
J. Kline
23:08
UChicago Medicine 7th Annual Updates from ASH 2021
ASH Review: Updates in Nonmalignant Hematology
Feat.
K. Cohen
33:44
UChicago Medicine 7th Annual Updates from ASH 2021
Myeloma Highlights of ASH 2021
Feat.
J. Mikhael
27:09
UChicago Medicine 7th Annual Updates from ASH 2021
Practice-Changing and Promising New Treatments in Myeloma
Feat.
B. Derman
25:47
UChicago Medicine 7th Annual Updates from ASH 2021
Advances in Cellular Therapy and Transplantation
Feat.
M. Nawas
22:21
UChicago Medicine 7th Annual Updates from ASH 2021
Post-ASH New Strategies in Myeloid Malignancies: AML Treatment
Feat.
A. Duvall
18:43
UChicago Medicine 7th Annual Updates from ASH 2021
ASH Review on Immunotherapies in Leukemia
Feat.
H. Liu
06:03
UChicago Medicine 7th Annual Updates from ASH 2021
Post-ASH Case Discussion: 59 y/o Male With Blurry Vision and Develop…
Feat.
S. Smith,
M. Drazer
12:13
UChicago Medicine 7th Annual Updates from ASH 2021
Post-ASH Case Discussion: 61 y/o Male With Right Neck Swelling Who D…
Feat.
S. Smith,
P. Riedell
09:49
UChicago Medicine 7th Annual Updates from ASH 2021
Post-ASH Case Discussion: 61 y/o Female With Progressive Fatigue Who…
Feat.
S. Smith,
A. Duvall
23:08
UChicago Medicine 7th Annual Updates from ASH 2021
Post-ASH 2021 Cellular Therapy Continuum: Initial Consult to Post-Tr…
Feat.
M. Phelan Lappe
07:26
UChicago Medicine 7th Annual Updates from ASH 2021
Post-ASH 2021 Faces of Cellular Therapy Nursing: Inpatient Phase
Feat.
S. Knesek
13:09
UChicago Medicine 7th Annual Updates from ASH 2021
Post-ASH 2021 Nursing Clinical Trials: It’s Not Trial By Fire
Feat.
A. Fadel
